JPMorgan Chase & Co’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,031
| Closed | -$8.98K | – | 6632 |
|
2025
Q1 | $8.98K | Buy |
2,031
+1,079
| +113% | +$4.77K | ﹤0.01% | 5460 |
|
2024
Q4 | $6.66K | Buy |
952
+65
| +7% | +$455 | ﹤0.01% | 5417 |
|
2024
Q3 | $12.9K | Buy |
887
+22
| +3% | +$319 | ﹤0.01% | 5277 |
|
2024
Q2 | $63.1K | Sell |
865
-10
| -1% | -$729 | ﹤0.01% | 4817 |
|
2024
Q1 | $51.8K | Sell |
875
-484
| -36% | -$28.6K | ﹤0.01% | 4961 |
|
2023
Q4 | $99.5K | Hold |
1,359
| – | – | ﹤0.01% | 4767 |
|
2023
Q3 | $52.8K | Sell |
1,359
-428
| -24% | -$16.6K | ﹤0.01% | 4890 |
|
2023
Q2 | $103K | Buy |
1,787
+1,663
| +1,341% | +$96K | ﹤0.01% | 4616 |
|
2023
Q1 | $8K | Hold |
124
| – | – | ﹤0.01% | 5323 |
|
2022
Q4 | $3K | Sell |
124
-146
| -54% | -$3.53K | ﹤0.01% | 5320 |
|
2022
Q3 | $8K | Buy |
270
+162
| +150% | +$4.8K | ﹤0.01% | 5108 |
|
2022
Q2 | $2K | Sell |
108
-829
| -88% | -$15.4K | ﹤0.01% | 5438 |
|
2022
Q1 | $76K | Sell |
937
-1,522
| -62% | -$123K | ﹤0.01% | 4855 |
|
2021
Q4 | $225K | Sell |
2,459
-592
| -19% | -$54.2K | ﹤0.01% | 4477 |
|
2021
Q3 | $382K | Sell |
3,051
-1,283
| -30% | -$161K | ﹤0.01% | 4096 |
|
2021
Q2 | $490K | Buy |
4,334
+1,560
| +56% | +$176K | ﹤0.01% | 4008 |
|
2021
Q1 | $421K | Buy |
2,774
+2,223
| +403% | +$337K | ﹤0.01% | 4137 |
|
2020
Q4 | $63K | Buy |
551
+87
| +19% | +$9.95K | ﹤0.01% | 4401 |
|
2020
Q3 | $37K | Sell |
464
-88
| -16% | -$7.02K | ﹤0.01% | 4367 |
|
2020
Q2 | $60K | Buy |
552
+137
| +33% | +$14.9K | ﹤0.01% | 4160 |
|
2020
Q1 | $45K | Sell |
415
-10
| -2% | -$1.08K | ﹤0.01% | 4171 |
|
2019
Q4 | $67K | Buy |
425
+2
| +0.5% | +$315 | ﹤0.01% | 4147 |
|
2019
Q3 | $62K | Buy |
423
+69
| +19% | +$10.1K | ﹤0.01% | 4164 |
|
2019
Q2 | $34K | Buy |
354
+93
| +36% | +$8.93K | ﹤0.01% | 4394 |
|
2019
Q1 | $28K | Sell |
261
-999
| -79% | -$107K | ﹤0.01% | 4417 |
|
2018
Q4 | $103K | Buy |
1,260
+1,126
| +840% | +$92K | ﹤0.01% | 4036 |
|
2018
Q3 | $22K | Buy |
+134
| New | +$22K | ﹤0.01% | 4559 |
|